Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Dual-Action Kinase Inhibitors and p38α Dephosphorylation
2026-09-10
The referenced preprint shows that selected kinase inhibitors can do more than block p38α MAP kinase activity: they can also accelerate WIP1-mediated dephosphorylation of the kinase activation loop. Structural and biochemical results connect this effect to an inhibitor-stabilized activation-loop conformation that exposes phospho-threonine, suggesting a strategy for designing inhibitors that combine catalytic blockade with phosphatase-directed regulation.
DdmDE Clears Plasmids by Bidirectional DNA Extrusion
2026-09-09
Yang et al. describe how the DdmDE defense module combines DNA-guided target recognition, force-assisted duplex opening, bidirectional single-stranded DNA extrusion, and site-specific cleavage to eliminate plasmids. The study shifts the mechanistic view of prokaryotic Argonaute defense from static target binding to a dynamic, kinetically controlled process with separable recognition, unwinding, and nuclease functions.
CH 223191 for Causal AhR Signaling Studies
2026-09-09
CH 223191 enables receptor-level testing of TCDD responses, CYP1A1 induction, and microbiota–tryptophan–AhR biology. This workflow-focused guide shows how to use the compound as an AhR signaling pathway inhibitor while separating validated product properties from exploratory ulcerative colitis applications.
Bergenin Reprograms γδT17 Cells in Psoriasis
2026-09-08
A 2026 Phytomedicine study identifies a PPARγ–PROX1–fatty acid oxidation pathway through which bergenin suppresses pathogenic γδT17 cells and reduces psoriasiform inflammation. Its combination of adoptive-transfer experiments, Seahorse metabolic analysis, co-immunoprecipitation, and ChIP-qPCR provides a mechanistic framework for selective IL-17A regulation.
Selective Autophagy Tunes IRF3 Antiviral Signaling
2026-09-08
Wu and colleagues showed that CALCOCO2/NDP52-dependent selective autophagy limits IRF3 stability in a virus load-dependent manner, while PSMD14 preserves IRF3 by removing K27-linked ubiquitin chains at lysine 313. The study defines a regulatory balance between type I interferon activation and immune suppression and offers a useful framework for analyzing transcription-factor turnover during antiviral signaling.
Neonatal iWAT Chromatin and Beige Adipogenesis
2026-09-07
This study integrates RNA-seq, H3K27ac ChIP-seq, imaging, qRT-PCR, and metabolic assays to define epigenetically active chromatin in neonatal inguinal white adipose tissue. Its principal advance is the identification of GABPα as a candidate regulator of beige adipocyte differentiation, linking chromatin activation to the metabolic and developmental biology of neonatal beige fat.
Moxidectin in Ergosterol-Targeted Antifungal Research
2026-09-07
Moxidectin is a macrocyclic lactone anthelmintic with an emerging use as a polyene-sensitizing tool in Candida albicans research. This practical guide connects assay design, formulation control, veterinary antiparasitic context, and troubleshooting for mechanism-driven translational studies.
Oltipraz for Nrf2 and MASLD Assays
2026-09-05
Oltipraz provides a defined Nrf2-activating comparator for separating phase II enzyme induction from the broader autophagy and ferroptosis effects observed with Qushi Huoxue ointment. This workflow connects chemoprevention research with MASLD assays while emphasizing solvent control, pathway-specific readouts, and cautious interpretation.
UHRF1, 5-mC, and Autophagy in Senile Osteoporosis
2026-09-04
The reference study identifies a mechanistic connection between UHRF1-dependent DNA 5-methylcytosine maintenance, super-enhancer redistribution, and TGM2-regulated autophagic flux in senile osteoporosis. Its multi-omics and perturbation framework links epigenetic remodeling to impaired mesenchymal stem cell osteogenesis and supports the UHRF1–TGM2 axis as a candidate route for investigating age-related bone loss.
Lipidated Nanophotosensitizers Disable Tumor EVs
2026-09-04
The reference study developed a palmitic acid-displayed nanophotosensitizer that traces tumor extracellular vesicles while simultaneously generating reactive oxygen species inside tumor cells and tumor-derived vesicles. This dual spatial activity suppressed primary tumor growth and prometastatic communication in multiple mouse models, providing a strategy that targets both the tumor source and its extracellular signaling network.
Estrogen–ERα/KRT19 Signaling in Papillary Thyroid Cancer
2026-09-03
The reference study integrates Oxford Nanopore Technologies sequencing, public thyroid cancer datasets, cellular perturbation experiments, and xenograft analysis to examine how estrogen promotes papillary thyroid carcinoma. Its central finding is that estrogen receptor α and keratin 19 form a signaling axis associated with PTC proliferation, migration, and invasion, while also highlighting the need for direct mechanistic and clinical validation.
Indole-3-pyruvic acid: Bench Workflows
2026-09-03
Indole-3-pyruvic acid connects auxin-pathway experiments with AhR-focused immune assays, giving researchers a versatile way to study metabolism across biological systems. This workflow guide translates published findings into practical setup, controls, handling advice, and troubleshooting steps.
Lysosomal β-Galactosidase Staining Kit Workflow
2026-09-02
Use the Lysosomal β-Galactosidase Staining Kit to visualize lysosomal acidic β-galactosidase activity in cultured cells and tissue sections while avoiding overinterpretation of blue staining as proof of senescence. This workflow connects chromogenic microscopy with HNSCC cisplatin-resistance research, providing practical controls for metabolic, epigenetic, and cellular senescence studies.
SERCA2 Dysfunction Drives Pulmonary Vascular Remodeling
2026-09-02
The reference study identifies SERCA2 dysfunction as an upstream driver of oxidative stress, inflammation, pulmonary artery smooth muscle cell activation, and pulmonary vascular remodeling. Its rescue experiments place the PPARγ–PGC1α–Nrf2 axis and reactive oxygen species downstream of SERCA2, providing a mechanistic framework for pulmonary hypertension research.
Indole-3-pyruvic acid: Applied Research Workflows
2026-09-01
Indole-3-pyruvic acid connects plant auxin-pathway experiments with AhR-focused immune assays and preclinical rheumatoid arthritis research. This workflow-led guide covers dosing logic, controls, mechanism checks, handling, and troubleshooting for more reproducible IPA studies.
8052 records 9/537 page Previous Next First page 上5页 678910 下5页 Last page